SPL 0.00% 9.6¢ starpharma holdings limited

Ann: DEP irinotecan outperforms in pancreatic cancer model, page-21

  1. 2,262 Posts.
    lightbulb Created with Sketch. 325
    What we need now is for a major media outlet to get hold of this news and run an article speaking to the fact that the DEP technology is continuing to record amazing results in both pre-clin and clinical trials in combination with multiple cancer fighting drugs and has now been patented by a major worldwide pharma.

    Headlines in major papers would do our SP no harm....
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.7¢ 9.8¢ 9.4¢ $31.52K 323.3K

Buyers (Bids)

No. Vol. Price($)
1 98090 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 103527 4
View Market Depth
Last trade - 14.53pm 29/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.